Topol says the unpublished results to which Wolfe is pointing don't pass the high bar of clinical proof--even though Celebrex may still pose a heart risk, and Pfizer may not have appropriately disclosed the results.
At Maria's school, half the students don't pass Arizona's proficiency exams, which means they don't meet the bar for basic knowledge in math, reading and science.